Turning Point Brands sees triple-digit growth of nicotine pouch sales in 2024

Turning Point Brands (TPB) has announced it made $11.2m in total sales of modern oral (nicotine pouch) products in the fourth quarter of 2024.

This represents about 12% of the total $93.7m in sales it made during that period, showing the increasing importance of nicotine pouches to the company’s overall health. The company said it helped offset low-single-digit declines in loose-leaf chew. Overall, the TPB oral segment (which includes pouches and moist snuff) saw a 25.8% increase in net sales, to $47.8m. The company added that oral products contributed just over half of total net sales for the fourth quarter of 2024 (51%).

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the TobaccoIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation